ARIAD PHARMACEUTICALS INC 4
4 · ARIAD PHARMACEUTICALS INC · Filed Jul 18, 2013
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Sale
Common Stock
2013-07-18$19.79/sh−8,000$158,286→ 62,096 total
Footnotes (1)
- [F1]These shares were sold to satisfy witholding tax requirements related to the vesting of performance stock units previously reported. These shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person in December 2012.